Cryptococcus gattii MENINGITIS IN AN IMMUNOCOMPROMISED PATIENT IN A HOSPITAL IN THE PERUVIAN AMAZON: CASE REPORT

Moreno-Soto A.A.; Cardenas-Golac R.J.; Paredes-Obando M.F.; Vasquez-Ascate J.J.; Sibina-Vela J.; Ramírez-García E.A.; Celis-Salinas J.C.; Casapia-Morales W.M. · Revista Peruana de Medicina Experimental y Salud Publica (2025) · DOI: 10.17843/rpmesp.2025.422.14195

Resumen

We report a case of Cryptococcus gattii meningitis in a patient with HIV in the Peruvian Amazon. A 36-year-old male patient with severe neurological symptoms that was diagnosed by cerebrospinal fluid culture. Although liposomal amphotericin B and flucytosine are considered the standard antifungal therapy, due to a lack of resources, an alternative treatment of amphotericin B deoxycholate and fluconazole was used. Even with this alternative, treatment faced challenges due to the persistence of the microorganism. This case highlights the importance of considering C. gattii in the differential diagnosis of cryptococcal meningitis in immunocompromised patients, even in areas where the prevalence of this pathogen is low. The effectiveness of treatment and the patient’s survival underscore the need for diagnostic and therapeutic strategies adapted to resource-limited settings.

Instituciones: Universidad Nacional de la Amazonía Peruana